37 related articles for article (PubMed ID: 16432052)
21. Imatinib mesylate attenuates myocardial remodeling through inhibition of platelet-derived growth factor and transforming growth factor activation in a rat model of hypertension.
Jang SW; Ihm SH; Choo EH; Kim OR; Chang K; Park CS; Kim HY; Seung KB
Hypertension; 2014 Jun; 63(6):1228-34. PubMed ID: 24591339
[TBL] [Abstract][Full Text] [Related]
22. Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27.
de Boer RA; Pokharel S; Flesch M; van Kampen DA; Suurmeijer AJ; Boomsma F; van Gilst WH; van Veldhuisen DJ; Pinto YM
J Mol Med (Berl); 2004 Oct; 82(10):678-87. PubMed ID: 15322702
[TBL] [Abstract][Full Text] [Related]
23. Specific MAP-kinase blockade protects against renal damage in homozygous TGR(mRen2)27 rats.
de Borst MH; Navis G; de Boer RA; Huitema S; Vis LM; van Gilst WH; van Goor H
Lab Invest; 2003 Dec; 83(12):1761-70. PubMed ID: 14691294
[TBL] [Abstract][Full Text] [Related]
24. Effects of angiotensin II subtype 1 receptor blockade on cardiac fibrosis and sarcoplasmic reticulum Ca2+ handling in hypertensive transgenic rats overexpressing the Ren2 gene.
Rothermund L; Pinto YM; Vetter R; Herfort N; Kossmehl P; Neumayer HH; Paul M; Kreutz R
J Hypertens; 2001 Aug; 19(8):1465-72. PubMed ID: 11518855
[TBL] [Abstract][Full Text] [Related]
25. Imatinib attenuates myocardial fibrosis in association with inhibition of the PDGFRα activity.
Ma LK; Li Q; He LF; Hua JS; Zhou JL; Yu H; Feng KF; Chen HW; Hu H; Wang L
Arq Bras Cardiol; 2012 Dec; 99(6):1082-91. PubMed ID: 23184075
[TBL] [Abstract][Full Text] [Related]
26. Imatinib attenuates end-organ damage in hypertensive homozygous TGR(mRen2)27 rats.
Schellings MW; Baumann M; van Leeuwen RE; Duisters RF; Janssen SH; Schroen B; Peutz-Kootstra CJ; Heymans S; Pinto YM
Hypertension; 2006 Mar; 47(3):467-74. PubMed ID: 16432052
[TBL] [Abstract][Full Text] [Related]
27. Alteration of intracellular Ca2(+)-handling and receptor regulation in hypertensive cardiac hypertrophy: insights from Ren2-transgenic rats.
Zolk O; Flesch M; Nickenig G; Schnabel P; Böhm M
Cardiovasc Res; 1998 Jul; 39(1):242-56. PubMed ID: 9764204
[TBL] [Abstract][Full Text] [Related]
28. The role of imatinib in the treatment of pulmonary hypertension.
Mucke H
Drugs Today (Barc); 2013 Mar; 49(3):203-11. PubMed ID: 23527324
[TBL] [Abstract][Full Text] [Related]
29. Myocardial fibrosis in chronic kidney disease: potential benefits of torasemide.
López B; González A; Hermida N; Laviades C; Díez J
Kidney Int Suppl; 2008 Dec; (111):S19-23. PubMed ID: 19034320
[TBL] [Abstract][Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
